American Association Of Pharmaceutical Scientists Announces 1998 Award Winners

November 18, 1998

Eight Pharmaceutical Scientists Recognized for Excellence San Francisco, CA -- November, 17, 1998 -- Eight pharmaceutical scientists were called to the stage at the American Association of Pharmaceutical Scientists' (AAPS) Annual Meeting opening ceremonies to receive awards for research achievement and advancing the pharmaceutical sciences.

AAPS-Dale E. Wurster Research Award in Pharmaceutics -- Sung Wan Kim, Ph.D.

Dr. Kim is among the first to apply basic polymer chemistry and physicochemical principles to develop modern hydrogel-based controlled drug delivery systems, thereby creating a new dimension in the design of zero-order drug delivery systems. His research spans from the development of controlled drug delivery systems for conventional drugs to sophisticated delivery systems for proteins, genes and cells. Dr. Kim is Professor of Pharmaceutics and Pharmaceutical Chemistry and Director of the Center for Controlled Chemical Delivery at the University of Utah.

AAPS Distinguished Service Award -- Vincent H.L. Lee, Ph.D.

Dr. Lee's research interests are in the areas of peptide/protein disposition and delivery, as well as mechanisms for ocular drug transport. He is an AAPS Fellow and served as AAPS President in 1996. Dr. Lee is a Professor and Chair of the Department of Pharmaceutical Sciences at the University of Southern California.

AAPS Research Achievement Award in Analysis and Pharmaceutical Quality -- Harry G. Brittain, Ph.D.

Dr. Brittain introduced the multi-disciplinary Materials Science approach now being used by many workers for the characterization of pharmaceutical solids. An AAPS Fellow, he is the vice president of Pharmaceutical and Chemical Development at Acute Therapeutics, Inc.

AAPS Research Achievement Award in Economic, Marketing and Management Sciences -- Jeffrey A. Kotzan, Ph.D.

Dr. Kotzan's research in policy and health outcomes is allowing policy makers to make more effective decisions regarding the pharmaceutical needs of impoverished populations. He is Professor of Clinical and Administrative Sciences at the University of Georgia.

AAPS Research Achievement Award in Medicinal and Natural Products Chemistry -- Kenner C. Rice, Ph.D.

Dr. Rice developed the NIS Opiate Total Synthesis, a practical methodology that offers independence from opium and opium poppy eradication as the preferred worldwide strategy for the elimination of illicit heroin production. He is Chief of the Laboratory of Medicinal Chemistry at the National institute of Diabetes, Digestive and Kidney Diseases at the National Institutes of Health.

AAPS Research Achievement Award in Pharmacokinetics, Pharmacodynamics and Drug Metabolism -- William J. Jusko, Ph.D.

Dr. Jusko has evolved many theoretical principles related to reversible metabolism and moment analysis in pharmacodynamics, particularly related to irreversible and indirect responses. His current research emphasizes the PK/PD of corticosteroids and immunosuppressive drugs. Dr. Jusko is Professor of Pharmaceuticals at the State University of New York (SUNY) at Buffalo School of Pharmacy.

New Investigator Grant in Pharmaceutics and Pharmaceutical Technology -- James E. Polli, Ph.D.

Dr. Polli's research interests include bioavailability considerations in drug design, dissolution, drug permeability, and bioequivalence. The one-time grant of $10,000 will support his research efforts in pharmaceutics, drug delivery and pharmaceutical technologies. Dr. Polli is Assistant Professor of Pharmaceutical Sciences at the University of Maryland at Baltimore School of Pharmacy.

New Investigator Grant in Pharmacokinetics, Pharmacodynamcis and Drug Metabolism -- David R. Taft, Ph.D.

Dr. Taft's research interests focus on the areas of renal drug transport and age-mediated changes in renal excretion. He will use his $10,000 grant to support his research efforts and training of graduate students. Dr. Taft is currently the thesis advisor for four Ph.D. and two M.S. candidates, and has developed and taught two courses required for pharmaceutical science Ph.D. candidates at Long Island University. He is Assistant Professor of Pharmaceutics at Long Island University.

More than 7,000 scientists are gathering in San Francisco to discuss and present the latest scientific and medical research advances of 1998, November 15-19, 1998.

AAPS is a professional, scientific society of more than 9,000 members employed in academia, industry, government and other research institutes worldwide. Founded in 1986, the goal of AAPS is to improve human health through the development of better pharmaceuticals. For more information about AAPS, visit our web site at www.aaps.org.
-end-


American Association of Pharmaceutical Scientists

Related Drug Delivery Articles from Brightsurf:

Modelling microswimmers for drug delivery
An international group of theoretical physicists led by Abdallah Daddi-Moussa-Ider from Düsseldorf, Germany, has modelled the motion of microscopic, motile bodies - either powered micro-machines or living cells - in viscous liquid drops, using the Navier-Stokes equations.

Millimetre-precision drug delivery to the brain
Focused ultrasound waves help ETH researchers to deliver drugs to the brain with pinpoint accuracy, in other words only to where their effect is desired.

New smart drug delivery system may help treatment for neurological disorders
A Rutgers-led team has created a smart drug delivery system that reduces inflammation in damaged nervous tissues and may help treat spinal cord injuries and other neurological disorders.

Novel drug delivery particles use neurotransmitters as a 'passport' into the brain
Drug-carrying lipid nanoparticles were created that incorporate neurotranmitters to help them cross the blood-brain barrier in mice.

Advances in nanoparticles as anticancer drug delivery vector: Need of this century
This review article provides a summary of current advances in the use of nanoparticles (NPs) as anticancer drug-delivery vectors.

Microcapsules for targeted drug delivery to cancer cells
A team of scientists from Peter the Great St. Petersburg Polytechnic University together with their colleagues developed a method of targeted drug delivery to cancer cells.

Improving drug delivery for brain tumor treatment
Despite improvements in drug delivery mechanisms, treating brain tumors has remained challenging.

Nanoparticle orientation offers a way to enhance drug delivery
MIT engineers have shown that they can enhance the performance of drug-delivery nanoparticles by controlling an inherent trait of chemical structures, known as chirality -- the 'handedness' of the structure.

News about drug delivery
Nanocontainer for drugs can have their pitfalls: If they are too heavily loaded, they will only dissolve poorly.

Deflating beach balls and drug delivery
Gwennou Coupier and his colleagues at Grenoble Alps University, Grenoble, France have shown that macroscopic-level models of the properties of microscopic hollow spheres agree very well with theoretical predictions.

Read More: Drug Delivery News and Drug Delivery Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.